Tendfo

Tendfo is a pioneering company specializing in the development, manufacture, and sale of advanced medical devices for intravenous interventions. Established on January 9, 2020, and located in the High Technology Development Area of Pujiang, Shanghai, the company operates from a state-of-the-art facility that includes a GMP Laboratory and a Purification Workshop, spanning over 1,400 square meters.

Tendfo's core product, TendviaTM, has been successfully used in critical medical procedures, such as the intervention for large pulmonary infarctions, demonstrating its efficacy in treating venous thromboembolism (VTE). The company's mission is to drive medical innovation to improve healthcare standards, alleviate patient suffering, and reduce medical costs, with a particular focus on blood clot removal interventions.

The company serves a diverse range of clients, including hospitals, medical research institutions, and healthcare providers, both domestically and internationally. Tendfo operates in the highly specialized market of medical equipment technology, offering not only products but also technical advice, technology transfer, and technical services. Its business model revolves around the sale of medical devices, as well as providing technical consultancy and services, thereby generating multiple revenue streams.

Keywords: intravenous intervention, medical devices, TendviaTM, pulmonary infarction, VTE treatment, healthcare innovation, blood clot removal, technical advisory, technology transfer, Shanghai.